Alta Partners reports 8.4% BioVie warrant stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BIOVIE INC. (BIVI) is reported to have a significant shareholder, Alta Partners LLC, which has filed a Schedule 13G indicating beneficial ownership of 687,321 shares of Class A Common Stock, all issuable upon exercise of warrants.
Alta Partners LLC reports this position as representing 8.4% of the outstanding Class A Common Stock, with sole voting and sole dispositive power over all 687,321 shares and no shared voting or dispositive power.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
Sole power to vote or to direct the vote financial
dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of BioVie Inc. (BIVI) does Alta Partners LLC report owning on this Schedule 13G?
Who signed the Schedule 13G reporting Alta Partners LLC’s holdings in BioVie Inc. (BIVI)?
AI-generated analysis. How Rhea-AI works. Not financial advice.